Handel Achieve Life Sciences, Inc. - ACHV CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | 0.27 | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.030779% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.013666% | ||||||||
| Gebyr natten over, tid | 22:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Nøglestatistikker
| Tidligere luk* | 4.87 |
| Åben* | 4.88 |
| 1-Års Ændring* | -1.21% |
| Dagens Spænd* | 4.79 - 4.95 |
| 52-Ugers Spænd | 2.00-8.13 |
| Gennemsnitlig Volumen (10 dage) | 83.23K |
| Gennemsnitlig Volumen (3 måneder) | 2.09M |
| Market Cap | 89.31M |
| P/E-forhold | -100.00K |
| Udestående aktier | 17.90M |
| Omsætning | N/A |
| EPS | -3.99 |
| Dividend (Udbytte %) | N/A |
| Beta | 1.46 |
| Næste indtjeningsopgørelse | Mar 8, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 4.91 | 0.03 | 0.61% | 4.88 | 4.95 | 4.79 |
| Jun 28, 2022 | 4.87 | -0.23 | -4.51% | 5.10 | 5.20 | 4.85 |
| Jun 27, 2022 | 5.10 | 0.02 | 0.39% | 5.08 | 5.14 | 4.91 |
| Jun 24, 2022 | 5.15 | 0.05 | 0.98% | 5.10 | 5.24 | 5.00 |
| Jun 23, 2022 | 5.06 | -0.08 | -1.56% | 5.14 | 5.32 | 5.06 |
| Jun 22, 2022 | 5.12 | 0.03 | 0.59% | 5.09 | 5.37 | 5.09 |
| Jun 21, 2022 | 5.29 | -0.24 | -4.34% | 5.53 | 5.63 | 5.28 |
| Jun 17, 2022 | 5.49 | 0.01 | 0.18% | 5.48 | 5.69 | 5.34 |
| Jun 16, 2022 | 5.48 | -0.35 | -6.00% | 5.83 | 5.83 | 5.45 |
| Jun 15, 2022 | 5.90 | -0.05 | -0.84% | 5.95 | 6.07 | 5.82 |
| Jun 14, 2022 | 5.94 | -0.13 | -2.14% | 6.07 | 6.12 | 5.87 |
| Jun 13, 2022 | 5.99 | -0.22 | -3.54% | 6.21 | 6.25 | 5.92 |
| Jun 10, 2022 | 6.39 | -0.16 | -2.44% | 6.55 | 6.55 | 6.39 |
| Jun 9, 2022 | 6.57 | 0.06 | 0.92% | 6.51 | 6.63 | 6.51 |
| Jun 8, 2022 | 6.58 | 0.19 | 2.97% | 6.39 | 6.60 | 6.39 |
| Jun 7, 2022 | 6.55 | 0.09 | 1.39% | 6.46 | 6.62 | 6.39 |
| Jun 6, 2022 | 6.47 | -0.14 | -2.12% | 6.61 | 6.71 | 6.46 |
| Jun 3, 2022 | 6.63 | -0.03 | -0.45% | 6.66 | 6.74 | 6.56 |
| Jun 2, 2022 | 6.60 | 0.04 | 0.61% | 6.56 | 6.63 | 6.56 |
| Jun 1, 2022 | 6.54 | -0.23 | -3.40% | 6.77 | 6.80 | 6.42 |
Achieve Life Sciences, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Årlig
- Pr kvartal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total omsætning | 5.062 | 0 | 0 | 0 | 0 | 0 |
| Omsætning | 5.062 | |||||
| Totale Driftsudgifter | 26.254 | 5.16 | 12.813 | 16.528 | 14.75 | 33.094 |
| Salgs/Generelle/Admin. Udgifter, Total | 8.933 | 3.531 | 6.945 | 6.854 | 7.868 | 9.128 |
| Forskning & Udvikling | 14.788 | 3.101 | 5.868 | 9.674 | 6.882 | 23.966 |
| Usædvanlig Udgift (Indkomst) | 2.533 | -1.472 | 0 | 0 | ||
| Driftsindtægter | -21.192 | -5.16 | -12.813 | -16.528 | -14.75 | -33.094 |
| Renteindkomst (Udgift), Netto Ikke-Drift | 0.203 | 0.021 | 0.171 | 0.17 | 0.069 | 0.017 |
| Andre, Netto | 0.86 | 0.115 | -0.045 | -0.037 | -0.049 | -0.075 |
| Netto Indkomst Før Skat | -20.129 | -13.634 | -12.687 | -16.395 | -14.73 | -33.152 |
| Netto Indkomst Efter Skat | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Netto Indkomst Før Ekstra Ting | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Netto Indkomst | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Fortyndet Netto Indkomst | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Fortyndet Vægtet Gennemsnit Aktier | 0.01361 | 0.02397 | 0.17551 | 0.41232 | 2.71891 | 8.11984 |
| Fortyndet EPS Uden Ekstraordinære Ting | -1478.62 | -441.473 | -72.2861 | -39.7628 | -5.41761 | -4.08284 |
| Fortyndet Normaliseret EPS | -1292.55 | -247.927 | -72.2861 | -39.7628 | -5.41761 | -4.08284 |
| Gain (Loss) on Sale of Assets | -8.61 | 0 | 0 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0 | 0 | 0 |
| Totale Driftsudgifter | 7.984 | 11.302 | 6.693 | 7.115 | 7.226 |
| Salgs/Generelle/Admin. Udgifter, Total | 2.342 | 2.075 | 2.102 | 2.609 | 2.838 |
| Forskning & Udvikling | 5.642 | 9.227 | 4.591 | 4.506 | 4.388 |
| Driftsindtægter | -7.984 | -11.302 | -6.693 | -7.115 | -7.226 |
| Renteindkomst (Udgift), Netto Ikke-Drift | 0.008 | 0.003 | 0.003 | 0.003 | -0.353 |
| Andre, Netto | -0.023 | -0.012 | -0.001 | -0.039 | 0.006 |
| Netto Indkomst Før Skat | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Netto Indkomst Efter Skat | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Netto Indkomst Før Ekstra Ting | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Netto Indkomst | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Fortyndet Netto Indkomst | -7.999 | -11.311 | -6.691 | -7.151 | -7.573 |
| Fortyndet Vægtet Gennemsnit Aktier | 6.13182 | 7.3906 | 9.45224 | 9.4682 | 9.45875 |
| Fortyndet EPS Uden Ekstraordinære Ting | -1.30451 | -1.53046 | -0.70787 | -0.75527 | -0.80063 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Fortyndet Normaliseret EPS | -1.30451 | -1.53046 | -0.70787 | -0.75527 | -0.80063 |
- Årlig
- Pr kvartal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 26.927 | 5.908 | 15.537 | 17.334 | 36.975 | 44.594 |
| Likvider og Kortsigtede Investeringer | 25.463 | 5.284 | 14.604 | 16.664 | 35.853 | 43.022 |
| Cash | 1.8 | |||||
| Likvider & Lignende | 11.931 | 5.284 | 9.515 | 16.664 | 35.853 | 43.022 |
| Kortsigtede Investeringer | 11.732 | 5.089 | ||||
| Totale Tilgodehavender, Netto | 0.51 | 0.009 | 0.007 | 0.008 | 0.153 | |
| Accounts Receivable - Trade, Net | 0.478 | 0.009 | 0.007 | 0.008 | ||
| Prepaid Expenses | 0.954 | 0.393 | 0.926 | 0.662 | 1.122 | 1.419 |
| Total Assets | 27.47 | 9.892 | 19.084 | 21.078 | 40.298 | 47.516 |
| Property/Plant/Equipment, Total - Net | 0.258 | 0.059 | 0.035 | 0.386 | 0.188 | 0.079 |
| Property/Plant/Equipment, Total - Gross | 1.707 | 1.144 | 0.755 | 0.986 | 0.82 | 0.366 |
| Accumulated Depreciation, Total | -1.449 | -1.085 | -0.72 | -0.6 | -0.632 | -0.287 |
| Other Long Term Assets, Total | 0.285 | 0.359 | 0.168 | 0.237 | 0.237 | 0.168 |
| Total Current Liabilities | 8.455 | 2.013 | 3.27 | 2.869 | 2.935 | 4.55 |
| Accounts Payable | 2.121 | 0.213 | 0.144 | 0.859 | 0.332 | 0.841 |
| Accrued Expenses | 6.045 | 1.773 | 3.126 | 2.01 | 2.603 | 3.709 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.057 | 0.027 | ||||
| Other Current Liabilities, Total | 0.232 | 0 | ||||
| Total Liabilities | 8.504 | 2.013 | 3.282 | 3.028 | 3.012 | 19.474 |
| Total Long Term Debt | 0.049 | 0 | 0 | 0 | 0 | 14.92 |
| Long Term Debt | 0.049 | 14.92 | ||||
| Total Equity | 18.966 | 7.879 | 15.802 | 18.05 | 37.286 | 28.042 |
| Common Stock | 0.029 | 0.012 | 0.018 | 0.041 | 0.076 | 0.079 |
| Additional Paid-In Capital | 213.239 | 20.556 | 41.161 | 63.709 | 97.64 | 121.545 |
| Retained Earnings (Accumulated Deficit) | -196.942 | -12.694 | -25.381 | -45.704 | -60.434 | -93.586 |
| Other Equity, Total | 2.64 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 |
| Total Liabilities & Shareholders’ Equity | 27.47 | 9.892 | 19.084 | 21.078 | 40.298 | 47.516 |
| Total Common Shares Outstanding | 0.01365 | 0.05978 | 0.33606 | 1.47426 | 6.11174 | 9.45354 |
| Other Current Assets, Total | 0.222 | 0 | ||||
| Goodwill, Net | 1.034 | 1.034 | 1.034 | 1.034 | 1.034 | |
| Intangibles, Net | 2.532 | 2.31 | 2.087 | 1.864 | 1.641 | |
| Deferred Income Tax | 0 | |||||
| Other Liabilities, Total | 0.012 | 0.159 | 0.077 | 0.004 | ||
| Total Preferred Shares Outstanding | 0.00058 | 0.00112 | 0 | |||
| Redeemable Preferred Stock | 0 | 0 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 30.439 | 42.431 | 34.733 | 44.594 | 37.692 |
| Likvider og Kortsigtede Investeringer | 29.637 | 42.001 | 33.312 | 43.022 | 36.337 |
| Likvider & Lignende | 29.637 | 42.001 | 33.312 | 43.022 | 36.337 |
| Prepaid Expenses | 0.802 | 0.43 | 1.27 | 1.419 | 1.355 |
| Total Assets | 33.662 | 45.565 | 37.799 | 47.516 | 40.614 |
| Property/Plant/Equipment, Total - Net | 0.141 | 0.121 | 0.1 | 0.079 | 0.049 |
| Goodwill, Net | 1.034 | 1.034 | 1.034 | 1.034 | 1.034 |
| Intangibles, Net | 1.809 | 1.752 | 1.697 | 1.641 | 1.586 |
| Other Long Term Assets, Total | 0.239 | 0.227 | 0.235 | 0.168 | 0.253 |
| Total Current Liabilities | 3.515 | 4.67 | 3.076 | 4.55 | 4.01 |
| Accounts Payable | 0.585 | 0.575 | 0.815 | 0.841 | 0.418 |
| Accrued Expenses | 2.93 | 4.095 | 2.261 | 3.709 | 3.592 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.574 | 4.711 | 3.099 | 19.474 | 19.181 |
| Total Long Term Debt | 0 | 0 | 0 | 14.92 | 15.171 |
| Other Liabilities, Total | 0.059 | 0.041 | 0.023 | 0.004 | 0 |
| Total Equity | 30.088 | 40.854 | 34.7 | 28.042 | 21.433 |
| Redeemable Preferred Stock | 0 | ||||
| Common Stock | 0.076 | 0.079 | 0.079 | 0.079 | 0.079 |
| Additional Paid-In Capital | 98.441 | 120.515 | 121.052 | 121.545 | 122.509 |
| Retained Earnings (Accumulated Deficit) | -68.433 | -79.744 | -86.435 | -93.586 | -101.159 |
| Other Equity, Total | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
| Total Liabilities & Shareholders’ Equity | 33.662 | 45.565 | 37.799 | 47.516 | 40.614 |
| Total Common Shares Outstanding | 6.14992 | 9.45222 | 9.45354 | 9.45354 | 9.47358 |
| Total Preferred Shares Outstanding | 0 | 0 | |||
| Totale Tilgodehavender, Netto | 0.151 | 0.153 | 0 | ||
| Long Term Debt | 14.92 | 15.171 |
- Årlig
- Pr kvartal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Netto indkomst/Startlinje | -20.129 | -10.583 | -12.687 | -16.395 | -14.73 | -33.152 |
| Likvider Fra Driftsaktiviteter | -29.683 | -9.107 | -10.623 | -15.216 | -13.474 | -29.44 |
| Likvider Fra Driftsaktiviteter | 0.188 | 0.059 | 0.06 | 0.031 | 0.032 | 0.027 |
| Ikke-Likvide Ting | 0.978 | 7.336 | 0.854 | 1.198 | 1.286 | 2.228 |
| Ændringer i Driftskapital | -10.72 | -3.091 | 0.928 | -0.273 | -0.285 | 1.234 |
| Likvider fra Investeringsaktiviteter | 10.608 | 12.648 | -5.125 | 5.036 | -0.017 | |
| Kapitaludgifter | -0.046 | -0.046 | -0.053 | -0.017 | ||
| Andre Investerings-Cash-Flow-Ting, Total | 10.654 | 12.648 | -5.079 | 5.089 | ||
| Likvider fra Financieringsaktiviteter | -0.002 | 2.001 | 19.757 | 17.325 | 32.68 | 36.61 |
| Financiering af Cash-Flow-Ting | -0.002 | 1.937 | 4.96 | 12.334 | 27.87 | |
| Udstedelse (Pensionering) af Aktier, Netto | 0 | 0.064 | 14.797 | 4.991 | 4.81 | 21.681 |
| Udenlandsk Børs Effekter | 0 | -0.001 | 0 | 0.004 | -0.001 | |
| Netto Ændring i Likviditet | -19.077 | 5.541 | 4.009 | 7.149 | 19.189 | 7.169 |
| Amortization | 0.223 | 0.222 | 0.223 | 0.223 | 0.223 | |
| Deferred Taxes | -3.051 | |||||
| Udstedelse (Pensionering) af Gæld, Netto | 0 | 14.929 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.999 | -19.31 | -26.001 | -33.152 | -7.573 |
| Cash From Operating Activities | -6.452 | -15.528 | -24.222 | -29.44 | -6.779 |
| Cash From Operating Activities | 0.064 | 0.127 | 0.188 | 0.25 | |
| Non-Cash Items | 0.565 | 1.204 | 1.734 | 2.228 | 1.12 |
| Changes in Working Capital | 0.918 | 2.451 | -0.143 | 1.234 | -0.386 |
| Cash From Investing Activities | 0 | 0 | 0 | ||
| Capital Expenditures | 0 | 0 | 0 | ||
| Cash From Financing Activities | 0.236 | 21.674 | 21.682 | 36.61 | 0.095 |
| Issuance (Retirement) of Stock, Net | 0.236 | 21.674 | 21.682 | 21.681 | 0.024 |
| Net Change in Cash | -6.216 | 6.148 | -2.541 | 7.169 | -6.685 |
| Financing Cash Flow Items | 0 | 0 | 0.071 | ||
| Foreign Exchange Effects | 0.002 | -0.001 | -0.001 | -0.001 | |
| Issuance (Retirement) of Debt, Net | 14.929 | ||||
| Amortization | 0.06 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| B. Riley Asset Management, LLC | Investment Advisor/Hedge Fund | 19.5228 | 3494000 | 0 | 2023-01-19 | HIGH |
| Contrarian Alpha Management, L.L.C. | Corporation | 7.643 | 1367873 | 1367873 | 2022-11-18 | |
| Francis Capital Management, LLC | Hedge Fund | 3.3204 | 594250 | 253100 | 2021-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.9462 | 348313 | -2307 | 2022-09-30 | LOW |
| Shay Capital LLC | Hedge Fund | 1.8998 | 340000 | -55759 | 2022-09-30 | HIGH |
| Long Focus Capital Management LLC | Hedge Fund | 1.7222 | 308220 | 130624 | 2022-09-30 | MED |
| Perkins Capital Management, Inc. | Investment Advisor | 1.2186 | 218100 | 0 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.7706 | 137910 | 13000 | 2022-09-30 | LOW |
| 683 Capital Management LLC | Hedge Fund | 0.6984 | 125000 | 0 | 2022-09-30 | MED |
| Clearline Capital LP | Hedge Fund | 0.671 | 120094 | 0 | 2022-09-30 | HIGH |
| LPL Financial LLC | Investment Advisor | 0.5582 | 99900 | -1800 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.478 | 85554 | 0 | 2022-09-30 | LOW |
| Fichthorn (John) | Individual Investor | 0.3073 | 55000 | 0 | 2023-01-19 | |
| Group One Trading, L.P. | Research Firm | 0.2373 | 42461 | 24247 | 2022-09-30 | HIGH |
| Renaissance Technologies LLC | Hedge Fund | 0.2162 | 38700 | -1000 | 2022-09-30 | HIGH |
| Bencich (John A.) | Individual Investor | 0.2063 | 36920 | 22000 | 2022-11-18 | MED |
| Citadel Advisors LLC | Hedge Fund | 0.1956 | 35000 | 21725 | 2022-09-30 | HIGH |
| Diametric Capital | Investment Advisor/Hedge Fund | 0.1937 | 34660 | 15153 | 2022-09-30 | HIGH |
| QS Investors, LLC | Investment Advisor/Hedge Fund | 0.1903 | 34050 | 33500 | 2021-06-30 | LOW |
| RBC Capital Markets Wealth Management | Research Firm | 0.1893 | 33880 | -16520 | 2022-09-30 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group +485000+
Handlende
65000+
Månedlkige, aktive klienter
$48000000+
Månedlig investeringsvolumen
$28000000+
Prøv nu Hævet hver måned
Handelslommeregner
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelskurtage
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Gearing
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Achieve Life Sciences, Inc. Company profile
Om Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. er en lægemiddelvirksomhed i den kliniske fase. Selskabet beskæftiger sig med udvikling og kommercialisering af cytisiniclin til rygestop og nikotinafhængighed. Selskabets produktkandidat, cytisiniclin, er en naturligt forekommende, plantebaseret alkaloid fra frøene af Laburnum anagyroides-planten. Cytisiniclin ligner strukturelt nikotin og har en virkningsmekanisme, der både er agonistisk og antagonistisk. Det hjælper med rygestop eller nikotinafhængighed ved at interagere med nikotinreceptorer i hjernen ved at reducere sværhedsgraden af nikotinafvænningssymptomer gennem agonistiske virkninger på nikotinreceptorer og ved at reducere den belønning og tilfredsstillelse, der er forbundet med nikotin, gennem antagonistiske egenskaber.
| Industry: | Biotechnology & Medical Research (NEC) |
22722 29Th Dr. Se
Suite 100
SEATTLE
WASHINGTON 98021
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com